News | February 21, 2007

Protector Sheet FDA Cleared for Management of Tendon Injuries

Feb. 22, 2007 - Integra LifeSciences Holdings Corp. has received FDA clearance to market TenoGlide Tendon Protector Sheet in the US. The product is indicated for the management and protection of tendon injuries in which there has been no substantial loss of tendon tissue. It is an advanced tendon protection device, composed of a porous matrix of cross-linked collagen and glycosaminoglycan (GAG). The collagen-GAG resorbable matrix provides a protective, biocompatible interface, which creates a favorable environment and gliding surface for tendon healing. Based on available
procedural data, Integra estimates that the worldwide market for the protection of tendon injuries is over $100 million.

"In our pre-clinical studies, the data indicate that the use of TenoGlide Tendon Protector Sheet during tendon repair in an animal model significantly reduced formation of scar tissue between the tendon and surrounding tissue, as compared to untreated controls," said Mayer Tenenhaus M.D., FACS, Associate Clinical Professor of Surgery/Plastic Surgery at University of California, San Diego.

Since tendon and peripheral nerve injuries often occur together, TenoGlide Tendon Protector Sheet can be used in conjunction with two previously cleared Integra products: NeuraGen Nerve Guide for completely transected nerves, and NeuraWrap Nerve Protector for nerve injuries, which include compressed or scarred nerves.

TenoGlide Tendon Protector Sheet will be sold by Integra's Extremity Reconstruction sales organization, which includes over 60 U.S. sales specialists focused on lower extremity fixation, upper extremity fixation, wound repair, tendon protection, and peripheral nerve repair/protection.

Related Content

Cambridge University Hospitals NHS Foundation Trust Implements Change Healthcare Enterprise Imaging
News | Enterprise Imaging | April 15, 2019
Change Healthcare successfully implemented its Radiology PACS (picture archiving and communication system), Image...
Visage 7 Enterprise Imaging Platform Highlighted at 2019 SBI/ACR Breast Imaging Symposium
News | Enterprise Imaging | April 05, 2019
Visage Imaging will be exhibiting the latest version of the Visage 7 Enterprise Imaging Platform at the 2019 Society of...
2-D and 3-D digital breast images

Since the widespread adoption of digital imaging and PACS, referring physicians seldom visit radiology reading rooms, substantially reducing a major source of feedback for radiologists. (Shown are 2-D and 3-D digital breast images.) A software module to be described April 5 at the SBI/ACR Breast Imaging Symposium has been providing that feedback for radiologists interpreting breast images at the University of Pittsburgh Medical Center. Image courtesy of Hologic

Feature | Women's Health | March 28, 2019 | By Greg Freiherr
Carestream Health has signed an agreement to sell its healthcare information systems (HCIS) business to Philips Healthcare. Image by geralt on Pixabay

Carestream Health has signed an agreement to sell its healthcare information systems (HCIS) business to Philips Healthcare. This includes its radiology and cardiology PACS and reporting software. Image by geralt on Pixabay 

News | Radiology Business | March 07, 2019
Carestream Health has signed an agr
Dianna Bardo, M.D., is the vice chair of radiology for clinical development at Phoenix Children’s Hospital.

Dianna Bardo, M.D., is the vice chair of radiology for clinical development at Phoenix Children’s Hospital. 

Sponsored Content | Webinar | Enterprise Imaging | March 06, 2019
The webinar "Replacing PACS and the Benefits of Enterprise Partnership in a Pediatric Hospital" will take place at 2
Sponsored Content | Videos | Information Technology | February 28, 2019
Andrew Deutsch, M.D., MBA, chairman and CEO of...